代謝型グルタミン酸受容体 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "代謝型グルタミン酸受容体" in Japanese language version.

refsWebsite

Global rank Japanese rank

57nih.gov

4^th place

24^th place

43doi.org

2^nd place

6^th place

8harvard.edu

18^th place

107^th place

3aspetjournals.org

6,663^rd place

low place

1znaturforsch.com

low place

1worldcat.org

5^th place

19^th place

1nature.com

234^th place

363^rd place

1bris.ac.uk

4,848^th place

low place

1web.archive.org

1^st place

1ebi.ac.uk

5,849^th place

7,098^th place

1semanticscholar.org

11^th place

1,537^th place

aspetjournals.org

bris.ac.uk

MRC (Medical Research Council), Glutamate receptors: Structures and functions. Archived 2007-09-15 at the Wayback Machine., University of Bristol Centre for Synaptic Plasticity (2003). Retrieved January 20, 2008.

doi.org

“Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons”. Neuropharmacology. 49 49 Suppl 1: 104–13. (2005). doi:10.1016/j.neuropharm.2005.05.012. PMID 16005029.
“A novel binding assay for metabotropic glutamate receptors using [3H L-quisqualic acid and recombinant receptors”] (subscription required). Zeitschrift für Naturforschung C 57 (3–4): 348–55. (2002). doi:10.1515/znc-2002-3-425. PMID 12064739.
“Characterization with [3H]quisqualate of group I metabotropic glutamate receptor subtype in rat central and peripheral excitable tissues”. Neurochemistry International 38 (3): 277–85. (March 2001). doi:10.1016/S0197-0186(00)00075-9. PMID 11099787.
“Quisqualate induces an inward current via mGluR activation in neocortical pyramidal neurons”. Brain Research 879 (1–2): 88–92. (October 2000). doi:10.1016/S0006-8993(00)02752-9. PMID 11011009.
“The role of glutamate in central nervous system health and disease--a review”. Veterinary Journal 173 (2): 278–86. (March 2007). doi:10.1016/j.tvjl.2005.11.007. PMID 16376594.
“The acid-sensitive, anesthetic-activated potassium leak channel, KCNK3, is regulated by 14-3-3β-dependent, protein kinase C (PKC)-mediated endocytic trafficking”. The Journal of Biological Chemistry 287 (39): 32354–66. (September 2012). doi:10.1074/jbc.M112.391458. PMC 3463364. PMID 22846993.
Sladeczek, F.; Momiyama, A.; Takahashi, T. (1993-09-22). “Presynaptic inhibitory action of a metabotropic glutamate receptor agonist on excitatory transmission in visual cortical neurons”. Proceedings. Biological Sciences 253 (1338): 297–303. doi:10.1098/rspb.1993.0117. ISSN 0962-8452. PMID 8234367.
“Characterization of modulatory effects of postsynaptic metabotropic glutamate receptors on calcium currents in rat nucleus tractus solitarius”. Brain Research 1024 (1–2): 212–24. (October 2004). doi:10.1016/j.brainres.2004.07.074. PMID 15451384.
“Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling”. Proceedings of the National Academy of Sciences of the United States of America 109 (40): 16342–7. (October 2012). Bibcode: 2012PNAS..10916342E. doi:10.1073/pnas.1205838109. PMC 3479612. PMID 22988116.
“Metabotropic glutamate receptors as novel targets for anxiety and stress disorders”. Nature Reviews. Drug Discovery 4 (2): 131–44. (February 2005). doi:10.1038/nrd1630. PMID 15665858.
“mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C”. Neuropharmacology 40 (7): 856–65. (June 2001). doi:10.1016/S0028-3908(01)00005-3. PMID 11378156.
“Neuronal and glial mGluR5 modulation prevents stretch-induced enhancement of NMDA receptor current”. Pharmacology Biochemistry and Behavior 73 (2): 287–98. (September 2002). doi:10.1016/S0091-3057(02)00825-0. PMID 12117582.
“Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus”. The Journal of Neuroscience 17 (19): 7503–22. (October 1997). doi:10.1523/JNEUROSCI.17-19-07503.1997. PMC 6573434. PMID 9295396.
“Characterization of mGluR5R, a novel, metabotropic glutamate receptor 5-related gene”. Brain Research. Molecular Brain Research 109 (1–2): 18–33. (December 2002). doi:10.1016/S0169-328X(02)00458-8. PMID 12531512.
“Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists”. Neuropharmacology 61 (8): 1419–23. (December 2011). doi:10.1016/j.neuropharm.2011.08.034. PMID 21903115.
“Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depression”. Journal of Neurogenetics 25 (4): 152–66. (December 2011). doi:10.3109/01677063.2011.627485. PMID 22091727.
“Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins”. Neuron 23 (3): 583–92. (July 1999). doi:10.1016/S0896-6273(00)80810-7. PMID 10433269.
“Understanding regulation of nerve cell death by mGluRs as a method for development of successful neuroprotective strategies”. Journal of the Neurological Sciences 229–230: 201–9. (March 2005). doi:10.1016/j.jns.2004.11.028. PMID 15760640.
“Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells”. Neuropharmacology 34 (8): 1089–98. (August 1995). doi:10.1016/0028-3908(95)00077-J. PMID 8532158.
“DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons”. The European Journal of Neuroscience 8 (1): 138–43. (January 1996). doi:10.1111/j.1460-9568.1996.tb01174.x. PMID 8713457.
“Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration”. The European Journal of Neuroscience 7 (9): 1906–13. (September 1995). doi:10.1111/j.1460-9568.1995.tb00712.x. PMID 8528465.
“Neuroprotective effects of group III mGluR in traumatic neuronal injury”. Journal of Neurotrauma 14 (12): 885–95. (December 1997). doi:10.1089/neu.1997.14.885. PMID 9475370.
“Development of metabotropic glutamate receptor ligands for neuroimaging”. Current Medical Imaging Reviews 3 (3): 186–205. (2007). doi:10.2174/157340507781387059.
“Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity”. European Journal of Pharmacology 219 (1): 173–4. (August 1992). doi:10.1016/0014-2999(92)90598-X. PMID 1397046.
“Activation of neuroprotective pathways by metabotropic group I glutamate receptors: a potential target for drug discovery?”. Annals of the New York Academy of Sciences 1053 (1): 55–73. (August 2005). Bibcode: 2005NYASA1053...55B. doi:10.1196/annals.1344.006. PMID 16179509.
“Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma”. Cancer Research 67 (5): 2298–305. (March 2007). doi:10.1158/0008-5472.CAN-06-3665. PMID 17332361.
“Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder”. Neuropsychopharmacology 33 (7): 1603–10. (June 2008). doi:10.1038/sj.npp.1301531. PMID 17712352.
“Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment”. Proceedings of the National Academy of Sciences of the United States of America 100 (23): 13668–73. (November 2003). Bibcode: 2003PNAS..10013668M. doi:10.1073/pnas.1835724100. PMC 263871. PMID 14593202.
“Correction of fragile X syndrome in mice”. Neuron 56 (6): 955–62. (December 2007). doi:10.1016/j.neuron.2007.12.001. PMC 2199268. PMID 18093519.
“Mechanism-based approaches to treating fragile X”. Pharmacology & Therapeutics 127 (1): 78–93. (July 2010). doi:10.1016/j.pharmthera.2010.02.008. PMID 20303363.
“NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development”. Psychopharmacology 169 (3–4): 215–33. (September 2003). doi:10.1007/s00213-003-1582-z. PMID 12955285.
“Neural synchrony in schizophrenia: from networks to new treatments”. Schizophrenia Bulletin 33 (4): 848–52. (July 2007). doi:10.1093/schbul/sbm062. PMC 2632315. PMID 17567628.
“Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats”. Journal of Neurophysiology 93 (4): 1989–2001. (April 2005). doi:10.1152/jn.00875.2004. PMID 15590730.
“Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats”. Science 281 (5381): 1349–52. (August 1998). Bibcode: 1998Sci...281.1349M. doi:10.1126/science.281.5381.1349. PMID 9721099.
“Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects”. Psychopharmacology 179 (1): 303–9. (April 2005). doi:10.1007/s00213-004-1982-8. PMID 15309376.
“Serotonin model of schizophrenia: emerging role of glutamate mechanisms”. Brain Research. Brain Research Reviews 31 (2–3): 302–12. (March 2000). doi:10.1016/S0165-0173(99)00046-6. PMID 10719157.
“Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial”. Nature Medicine 13 (9): 1102–7. (September 2007). doi:10.1038/nm1632. PMID 17767166.
“Effects of LY354740, a novel glutamatergic metabotropic agonist, on nonhuman primate hypothalamic-pituitary-adrenal axis and noradrenergic function”. CNS Spectrums 6 (7): 607–12, 617. (July 2001). doi:10.1017/S1092852900002157. PMID 15573025.
“Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: the metabotropic pathway”. Molecular and Cellular Endocrinology 382 (1): 170–7. (January 2014). doi:10.1016/j.mce.2013.09.025. PMID 24080311.
“Glutamate stimulates inositol phosphate formation in striatal neurones”. Nature 317 (6039): 717–9. (1985). Bibcode: 1985Natur.317..717S. doi:10.1038/317717a0. PMID 2865680.
“A new type of glutamate receptor linked to inositol phospholipid metabolism”. Nature 325 (6104): 531–3. (1987). Bibcode: 1987Natur.325..531S. doi:10.1038/325531a0. PMID 2880300.
“Sequence and expression of a metabotropic glutamate receptor”. Nature 349 (6312): 760–5. (February 1991). Bibcode: 1991Natur.349..760M. doi:10.1038/349760a0. PMID 1847995.
“AMPA receptor-mediated regulation of a Gi-protein in cortical neurons”. Nature 389 (6650): 502–4. (October 1997). Bibcode: 1997Natur.389..502W. doi:10.1038/39062. PMID 9333240.

ebi.ac.uk

InterPro. InterPro: IPR001786 Metabotropic glutamate receptor 4. Retrieved on January 20, 2008.

harvard.edu

ui.adsabs.harvard.edu

“Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling”. Proceedings of the National Academy of Sciences of the United States of America 109 (40): 16342–7. (October 2012). Bibcode: 2012PNAS..10916342E. doi:10.1073/pnas.1205838109. PMC 3479612. PMID 22988116.
“Activation of neuroprotective pathways by metabotropic group I glutamate receptors: a potential target for drug discovery?”. Annals of the New York Academy of Sciences 1053 (1): 55–73. (August 2005). Bibcode: 2005NYASA1053...55B. doi:10.1196/annals.1344.006. PMID 16179509.
“Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment”. Proceedings of the National Academy of Sciences of the United States of America 100 (23): 13668–73. (November 2003). Bibcode: 2003PNAS..10013668M. doi:10.1073/pnas.1835724100. PMC 263871. PMID 14593202.
“Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats”. Science 281 (5381): 1349–52. (August 1998). Bibcode: 1998Sci...281.1349M. doi:10.1126/science.281.5381.1349. PMID 9721099.
“Glutamate stimulates inositol phosphate formation in striatal neurones”. Nature 317 (6039): 717–9. (1985). Bibcode: 1985Natur.317..717S. doi:10.1038/317717a0. PMID 2865680.
“A new type of glutamate receptor linked to inositol phospholipid metabolism”. Nature 325 (6104): 531–3. (1987). Bibcode: 1987Natur.325..531S. doi:10.1038/325531a0. PMID 2880300.
“Sequence and expression of a metabotropic glutamate receptor”. Nature 349 (6312): 760–5. (February 1991). Bibcode: 1991Natur.349..760M. doi:10.1038/349760a0. PMID 1847995.
“AMPA receptor-mediated regulation of a Gi-protein in cortical neurons”. Nature 389 (6650): 502–4. (October 1997). Bibcode: 1997Natur.389..502W. doi:10.1038/39062. PMID 9333240.

nature.com

If not otherwise specified in table:TABLE 1 Classification of the metabotropic glutamate (mGlu) receptors From the following article:

nih.gov

pubmed.ncbi.nlm.nih.gov

“Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons”. Neuropharmacology. 49 49 Suppl 1: 104–13. (2005). doi:10.1016/j.neuropharm.2005.05.012. PMID 16005029.
“A novel binding assay for metabotropic glutamate receptors using [3H L-quisqualic acid and recombinant receptors”] (subscription required). Zeitschrift für Naturforschung C 57 (3–4): 348–55. (2002). doi:10.1515/znc-2002-3-425. PMID 12064739.
“Characterization with [3H]quisqualate of group I metabotropic glutamate receptor subtype in rat central and peripheral excitable tissues”. Neurochemistry International 38 (3): 277–85. (March 2001). doi:10.1016/S0197-0186(00)00075-9. PMID 11099787.
“Quisqualate induces an inward current via mGluR activation in neocortical pyramidal neurons”. Brain Research 879 (1–2): 88–92. (October 2000). doi:10.1016/S0006-8993(00)02752-9. PMID 11011009.
“The role of glutamate in central nervous system health and disease--a review”. Veterinary Journal 173 (2): 278–86. (March 2007). doi:10.1016/j.tvjl.2005.11.007. PMID 16376594.
“The acid-sensitive, anesthetic-activated potassium leak channel, KCNK3, is regulated by 14-3-3β-dependent, protein kinase C (PKC)-mediated endocytic trafficking”. The Journal of Biological Chemistry 287 (39): 32354–66. (September 2012). doi:10.1074/jbc.M112.391458. PMC 3463364. PMID 22846993.
Sladeczek, F.; Momiyama, A.; Takahashi, T. (1993-09-22). “Presynaptic inhibitory action of a metabotropic glutamate receptor agonist on excitatory transmission in visual cortical neurons”. Proceedings. Biological Sciences 253 (1338): 297–303. doi:10.1098/rspb.1993.0117. ISSN 0962-8452. PMID 8234367.
“Characterization of modulatory effects of postsynaptic metabotropic glutamate receptors on calcium currents in rat nucleus tractus solitarius”. Brain Research 1024 (1–2): 212–24. (October 2004). doi:10.1016/j.brainres.2004.07.074. PMID 15451384.
“Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling”. Proceedings of the National Academy of Sciences of the United States of America 109 (40): 16342–7. (October 2012). Bibcode: 2012PNAS..10916342E. doi:10.1073/pnas.1205838109. PMC 3479612. PMID 22988116.
“Metabotropic glutamate receptors as novel targets for anxiety and stress disorders”. Nature Reviews. Drug Discovery 4 (2): 131–44. (February 2005). doi:10.1038/nrd1630. PMID 15665858.
“mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C”. Neuropharmacology 40 (7): 856–65. (June 2001). doi:10.1016/S0028-3908(01)00005-3. PMID 11378156.
“Neuronal and glial mGluR5 modulation prevents stretch-induced enhancement of NMDA receptor current”. Pharmacology Biochemistry and Behavior 73 (2): 287–98. (September 2002). doi:10.1016/S0091-3057(02)00825-0. PMID 12117582.
“Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus”. The Journal of Neuroscience 17 (19): 7503–22. (October 1997). doi:10.1523/JNEUROSCI.17-19-07503.1997. PMC 6573434. PMID 9295396.
“Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro” (abstract). Molecular Pharmacology 47 (5): 1057–64. (May 1995). PMID 7746273.
“Characterization of mGluR5R, a novel, metabotropic glutamate receptor 5-related gene”. Brain Research. Molecular Brain Research 109 (1–2): 18–33. (December 2002). doi:10.1016/S0169-328X(02)00458-8. PMID 12531512.
“Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists”. Neuropharmacology 61 (8): 1419–23. (December 2011). doi:10.1016/j.neuropharm.2011.08.034. PMID 21903115.
“Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depression”. Journal of Neurogenetics 25 (4): 152–66. (December 2011). doi:10.3109/01677063.2011.627485. PMID 22091727.
“Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins”. Neuron 23 (3): 583–92. (July 1999). doi:10.1016/S0896-6273(00)80810-7. PMID 10433269.
“Understanding regulation of nerve cell death by mGluRs as a method for development of successful neuroprotective strategies”. Journal of the Neurological Sciences 229–230: 201–9. (March 2005). doi:10.1016/j.jns.2004.11.028. PMID 15760640.
“Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells”. Neuropharmacology 34 (8): 1089–98. (August 1995). doi:10.1016/0028-3908(95)00077-J. PMID 8532158.
“DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons”. The European Journal of Neuroscience 8 (1): 138–43. (January 1996). doi:10.1111/j.1460-9568.1996.tb01174.x. PMID 8713457.
“Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration”. The European Journal of Neuroscience 7 (9): 1906–13. (September 1995). doi:10.1111/j.1460-9568.1995.tb00712.x. PMID 8528465.
“Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury” (abstract). The Journal of Pharmacology and Experimental Therapeutics 290 (1): 112–20. (July 1999). PMID 10381766.
“Neuroprotective effects of group III mGluR in traumatic neuronal injury”. Journal of Neurotrauma 14 (12): 885–95. (December 1997). doi:10.1089/neu.1997.14.885. PMID 9475370.
“Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity”. European Journal of Pharmacology 219 (1): 173–4. (August 1992). doi:10.1016/0014-2999(92)90598-X. PMID 1397046.
“Activation of neuroprotective pathways by metabotropic group I glutamate receptors: a potential target for drug discovery?”. Annals of the New York Academy of Sciences 1053 (1): 55–73. (August 2005). Bibcode: 2005NYASA1053...55B. doi:10.1196/annals.1344.006. PMID 16179509.
“Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma”. Cancer Research 67 (5): 2298–305. (March 2007). doi:10.1158/0008-5472.CAN-06-3665. PMID 17332361.
“Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder”. Neuropsychopharmacology 33 (7): 1603–10. (June 2008). doi:10.1038/sj.npp.1301531. PMID 17712352.
“Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment”. Proceedings of the National Academy of Sciences of the United States of America 100 (23): 13668–73. (November 2003). Bibcode: 2003PNAS..10013668M. doi:10.1073/pnas.1835724100. PMC 263871. PMID 14593202.
“Correction of fragile X syndrome in mice”. Neuron 56 (6): 955–62. (December 2007). doi:10.1016/j.neuron.2007.12.001. PMC 2199268. PMID 18093519.
“Mechanism-based approaches to treating fragile X”. Pharmacology & Therapeutics 127 (1): 78–93. (July 2010). doi:10.1016/j.pharmthera.2010.02.008. PMID 20303363.
“NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development”. Psychopharmacology 169 (3–4): 215–33. (September 2003). doi:10.1007/s00213-003-1582-z. PMID 12955285.
“Neural synchrony in schizophrenia: from networks to new treatments”. Schizophrenia Bulletin 33 (4): 848–52. (July 2007). doi:10.1093/schbul/sbm062. PMC 2632315. PMID 17567628.
“Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats”. Journal of Neurophysiology 93 (4): 1989–2001. (April 2005). doi:10.1152/jn.00875.2004. PMID 15590730.
“Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats”. Science 281 (5381): 1349–52. (August 1998). Bibcode: 1998Sci...281.1349M. doi:10.1126/science.281.5381.1349. PMID 9721099.
“Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects”. Psychopharmacology 179 (1): 303–9. (April 2005). doi:10.1007/s00213-004-1982-8. PMID 15309376.
“Serotonin model of schizophrenia: emerging role of glutamate mechanisms”. Brain Research. Brain Research Reviews 31 (2–3): 302–12. (March 2000). doi:10.1016/S0165-0173(99)00046-6. PMID 10719157.
“Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial”. Nature Medicine 13 (9): 1102–7. (September 2007). doi:10.1038/nm1632. PMID 17767166.
“Effects of LY354740, a novel glutamatergic metabotropic agonist, on nonhuman primate hypothalamic-pituitary-adrenal axis and noradrenergic function”. CNS Spectrums 6 (7): 607–12, 617. (July 2001). doi:10.1017/S1092852900002157. PMID 15573025.
“Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: the metabotropic pathway”. Molecular and Cellular Endocrinology 382 (1): 170–7. (January 2014). doi:10.1016/j.mce.2013.09.025. PMID 24080311.
“Glutamate stimulates inositol phosphate formation in striatal neurones”. Nature 317 (6039): 717–9. (1985). Bibcode: 1985Natur.317..717S. doi:10.1038/317717a0. PMID 2865680.
“A new type of glutamate receptor linked to inositol phospholipid metabolism”. Nature 325 (6104): 531–3. (1987). Bibcode: 1987Natur.325..531S. doi:10.1038/325531a0. PMID 2880300.
“Sequence and expression of a metabotropic glutamate receptor”. Nature 349 (6312): 760–5. (February 1991). Bibcode: 1991Natur.349..760M. doi:10.1038/349760a0. PMID 1847995.
“The glutamate receptor ion channels”. Pharmacological Reviews 51 (1): 7–61. (March 1999). PMID 10049997.
“AMPA receptor-mediated regulation of a Gi-protein in cortical neurons”. Nature 389 (6650): 502–4. (October 1997). Bibcode: 1997Natur.389..502W. doi:10.1038/39062. PMID 9333240.

ncbi.nlm.nih.gov

“The acid-sensitive, anesthetic-activated potassium leak channel, KCNK3, is regulated by 14-3-3β-dependent, protein kinase C (PKC)-mediated endocytic trafficking”. The Journal of Biological Chemistry 287 (39): 32354–66. (September 2012). doi:10.1074/jbc.M112.391458. PMC 3463364. PMID 22846993.
“Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling”. Proceedings of the National Academy of Sciences of the United States of America 109 (40): 16342–7. (October 2012). Bibcode: 2012PNAS..10916342E. doi:10.1073/pnas.1205838109. PMC 3479612. PMID 22988116.
“Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus”. The Journal of Neuroscience 17 (19): 7503–22. (October 1997). doi:10.1523/JNEUROSCI.17-19-07503.1997. PMC 6573434. PMID 9295396.
“Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment”. Proceedings of the National Academy of Sciences of the United States of America 100 (23): 13668–73. (November 2003). Bibcode: 2003PNAS..10013668M. doi:10.1073/pnas.1835724100. PMC 263871. PMID 14593202.
“Correction of fragile X syndrome in mice”. Neuron 56 (6): 955–62. (December 2007). doi:10.1016/j.neuron.2007.12.001. PMC 2199268. PMID 18093519.
“Neural synchrony in schizophrenia: from networks to new treatments”. Schizophrenia Bulletin 33 (4): 848–52. (July 2007). doi:10.1093/schbul/sbm062. PMC 2632315. PMID 17567628.

pmc.ncbi.nlm.nih.gov

“The acid-sensitive, anesthetic-activated potassium leak channel, KCNK3, is regulated by 14-3-3β-dependent, protein kinase C (PKC)-mediated endocytic trafficking”. The Journal of Biological Chemistry 287 (39): 32354–66. (September 2012). doi:10.1074/jbc.M112.391458. PMC 3463364. PMID 22846993.
“Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling”. Proceedings of the National Academy of Sciences of the United States of America 109 (40): 16342–7. (October 2012). Bibcode: 2012PNAS..10916342E. doi:10.1073/pnas.1205838109. PMC 3479612. PMID 22988116.
“Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus”. The Journal of Neuroscience 17 (19): 7503–22. (October 1997). doi:10.1523/JNEUROSCI.17-19-07503.1997. PMC 6573434. PMID 9295396.
“Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment”. Proceedings of the National Academy of Sciences of the United States of America 100 (23): 13668–73. (November 2003). Bibcode: 2003PNAS..10013668M. doi:10.1073/pnas.1835724100. PMC 263871. PMID 14593202.
“Correction of fragile X syndrome in mice”. Neuron 56 (6): 955–62. (December 2007). doi:10.1016/j.neuron.2007.12.001. PMC 2199268. PMID 18093519.
“Neural synchrony in schizophrenia: from networks to new treatments”. Schizophrenia Bulletin 33 (4): 848–52. (July 2007). doi:10.1093/schbul/sbm062. PMC 2632315. PMID 17567628.

semanticscholar.org

“Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats”. Journal of Neurophysiology 93 (4): 1989–2001. (April 2005). doi:10.1152/jn.00875.2004. PMID 15590730.

web.archive.org

MRC (Medical Research Council), Glutamate receptors: Structures and functions. Archived 2007-09-15 at the Wayback Machine., University of Bristol Centre for Synaptic Plasticity (2003). Retrieved January 20, 2008.

worldcat.org

search.worldcat.org

Sladeczek, F.; Momiyama, A.; Takahashi, T. (1993-09-22). “Presynaptic inhibitory action of a metabotropic glutamate receptor agonist on excitatory transmission in visual cortical neurons”. Proceedings. Biological Sciences 253 (1338): 297–303. doi:10.1098/rspb.1993.0117. ISSN 0962-8452. PMID 8234367.

znaturforsch.com

“A novel binding assay for metabotropic glutamate receptors using [3H L-quisqualic acid and recombinant receptors”] (subscription required). Zeitschrift für Naturforschung C 57 (3–4): 348–55. (2002). doi:10.1515/znc-2002-3-425. PMID 12064739.

代謝型グルタミン酸受容体 (Japanese Wikipedia)

aspetjournals.org

molpharm.aspetjournals.org

jpet.aspetjournals.org

pharmrev.aspetjournals.org

bris.ac.uk

doi.org

ebi.ac.uk

harvard.edu

ui.adsabs.harvard.edu

nature.com

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

semanticscholar.org

web.archive.org

worldcat.org

search.worldcat.org

znaturforsch.com